Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI Technology
Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI Technology
VANCOUVER, BC / ACCESSWIRE / April 17, 2024 / Blackhawk Growth Corp. (CSE:BLR)(Frankfurt:0JJ) (the "Corporation" or "Blackhawk"), is pleased to provide an update on Hardenbrook portfolio company - Asthmatic AI.
不列颠哥伦比亚省温哥华/ACCESSWIRE/2024年4月17日/Blackhawk Growth Corp.(CSE: BLR)(法兰克福:0JJ)(“公司” 或 “黑鹰”)很高兴提供哈登布鲁克投资组合公司Asthmatic AI的最新情况。
We are pleased to report that Asthmatic AI, a Hardenbrook and Life AI Corp asset ( has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma.
我们很高兴地向大家报告,Asthmatic AI(哈登布鲁克和Life AI Corp的资产)已经完成了50名人体临床试验的参与者,目前正在研究接下来的250名参与者,开发用于哮喘临床管理的哮喘发作预测技术。
Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition.
独特的是,Asthmatic AI通过智能手机使用可穿戴设备和移动应用程序来收集数据,评估哮喘发作的风险,然后在哮喘发作之前进行干预。人工智能模型将个人的生物物理信息(例如心率、呼吸频率、心率变异性、血压、咳嗽和喘息率)与公共卫生数据、花粉和位置数据进行交叉引用,以解释个人的哮喘发作风险。根据世界卫生组织的数据,每天报告超过1000例哮喘死亡病例,以及社会、就业、教育和家庭的负担,Asthmatic AI为管理这种严重的健康状况提出了一种新的解决方案。
Hardenbrook Group works with world class research-intensive organisations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally.
哈登布鲁克集团与世界一流的研究密集型组织合作,寻找有价值的知识产权进行投资和商业化。这使Blackhawk能够孵化并购或将这些新的创新公司分拆为全球证券交易所的新上市。
Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.
哈登布鲁克已将其专注于健康科技人工智能的公司投资组合,包括哮喘人工智能、情绪人工智能和自闭症人工智能,与健康科技人工智能相关的大量项目合并,这些项目将在近期推出。Life AI Corp将成为所有健康科技人工智能公司的控股公司,同时也准备分拆并上市上市。
Blackhawk CEO Justin Hanka (left) and Chairman Anoosh Manzoori (right). The Board's focus is on scalable technology opportunities particularly in AI, health and enviro-tech.
黑鹰首席执行官贾斯汀·汉卡(左)和董事长阿努什·曼佐里(右)。董事会的重点是可扩展的技术机会,尤其是在人工智能、健康和环境技术领域。
About Blackhawk Growth
关于《黑鹰成长》
Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high growth companies.
Blackhawk是一家投资控股公司,希望通过收购和发展高增长公司为其股东创造可观的价值。
To receive our latest updates, please register here:
要接收我们的最新更新,请在此处注册:
For more information on Hardenbrook:
有关哈登布鲁克的更多信息:
For more information about Life AI Corp:
有关 Life AI Corp 的更多信息:
Contact
联系我们
Justin Hanka. Chief Executive Officer
justin@hardenbrook.group
61433140886
贾斯汀·汉卡。首席执行官
justin@hardenbrook.group
61433140886
Cautionary Note Regarding Forward-Looking Statement
关于前瞻性陈述的警示性说明
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at . Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.
本新闻稿中的所有陈述,除历史事实陈述外,均为适用证券法所指的有关公司的 “前瞻性信息”。公司提供前瞻性陈述的目的是传达有关当前预期和未来计划的信息,并提醒读者,此类陈述可能不适用于其他目的。就其性质而言,这些信息存在固有的风险和不确定性,这些风险和不确定性可能是一般性的,也可能是具体的,有可能导致预期、预测、预测、预测或结论不准确,假设可能不正确,目标、战略目标和优先事项无法实现。这些风险和不确定性包括但不限于公司根据公司SEDAR简介在公开文件中确定和报告的风险和不确定性,网址为。尽管公司试图确定可能导致实际行动、事件或结果与前瞻性信息中描述的重大差异的重要因素,但可能还有其他因素导致行动、事件或结果与预期、估计或预期不符。无法保证此类信息会被证明是准确的,因为实际结果和未来事件可能与此类声明中的预期存在重大差异。除非法律要求,否则公司不打算或义务更新或修改任何前瞻性信息,无论是由于新信息、未来事件还是其他原因。
SOURCE: Blackhawk Growth Corp.
资料来源:黑鹰增长公司